Synthetic Aragonite (CaCO3) as a Potential Additive in Calcium Phosphate Cements: Evaluation in Tris-Free SBF at 37°C

Conventional SBF (simulated/synthetic body fluid) solutions are buffered at pH 7.4°C and 37°C using 50 mM Tris [(HOCH2)3CNH2]. Tris is not present in human blood or metabolism and its high concentration makes it the third major component of SBF solutions. All three crystalline polymorphs of calcium...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Ceramic Society Vol. 97; no. 10; pp. 3052 - 3061
Main Authors Lee, Jin H., Madden, Andrew S., Kriven, Waltraud M., Tas, A. Cuneyt
Format Journal Article
LanguageEnglish
Published Columbus Blackwell Publishing Ltd 01.10.2014
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Conventional SBF (simulated/synthetic body fluid) solutions are buffered at pH 7.4°C and 37°C using 50 mM Tris [(HOCH2)3CNH2]. Tris is not present in human blood or metabolism and its high concentration makes it the third major component of SBF solutions. All three crystalline polymorphs of calcium carbonate (calcite, aragonite and vaterite) have never been tested simultaneously in an SBF solution. This study presents the SBF‐testing of the particles of these polymorphs at 37°C in Na‐L‐lactate (22 mM)‐buffered Lac‐SBF solution. While the calcite rhombohedra remained completely inert in the solution, vaterite spherulites and aragonite needles accrued apatitic CaP (calcium phosphate) deposits on their surfaces. Mg‐doped (1050 ppm) synthetic aragonite particles did not transform into calcite for 96 h in the Lac‐SBF solution while increasing their BET surface area by about 560% via the apatitic CaP deposits. Given the well‐established use of calcite powders in CaP cement formulations, synthetic aragonite particles may be a potential replacement for calcite due to their rapid response to blood plasma‐like solutions in between 24 and 48 h at 37°C.
Bibliography:US Department of Energy - No. DE-FG02-07 ER 46453; No. DE-FG02-07 ER 46471
ark:/67375/WNG-KCCHM3K3-2
ArticleID:JACE13124
istex:561A40E0BBF75BBEF32556E7E52275BDB1A5B9AC
AFOSR - No. 919 AF Sub TX UTA II-000843
ISSN:0002-7820
1551-2916
DOI:10.1111/jace.13124